1. Home
  2. TLIH vs COCP Comparison

TLIH vs COCP Comparison

Compare TLIH & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ten-League International Holdings Limited Ordinary Shares

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$5.68

Market Cap

16.2M

Sector

N/A

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

SELL

Current Price

$1.01

Market Cap

19.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TLIH
COCP
Founded
1998
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
19.2M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
TLIH
COCP
Price
$5.68
$1.01
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
1.2K
★ 31.9K
Earning Date
09-30-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.65
EPS
★ N/A
N/A
Revenue
N/A
★ $12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.34
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.76
52 Week High
$6.08
$2.03

Technical Indicators

Market Signals
Indicator
TLIH
COCP
Relative Strength Index (RSI) 44.35 55.79
Support Level $5.22 $0.91
Resistance Level $5.90 $1.11
Average True Range (ATR) 0.37 0.07
MACD -0.00 0.01
Stochastic Oscillator 81.05 84.21

Price Performance

Historical Comparison
TLIH
COCP

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: